TELO (Telomir Pharmaceuticals, Inc. Common Stock) Stock Analysis - Analyst Ratings
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a publicly traded Healthcare sector company. As of May 20, 2026, TELO trades at $1.28 with a market cap of $81.84M and a P/E ratio of 0.00. TELO moved +3.69% today. Year to date, TELO is -8.96%; over the trailing twelve months it is -51.97%. Its 52-week range spans $1.05 to $7.08. Rallies surfaces TELO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate TELO?
The average price target is $0.00.
TELO Key Metrics
Key financial metrics for TELO
Metric
Value
Price
$1.28
Market Cap
$81.84M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$7.08
52-Week Low
$1.05
Volume
59.10K
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
TELO Analyst Consensus
TELO analyst coverage data. Average price target: $0.00.